Switzerland · Biotechnology startup
Switzerland · MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.
Funding reportedLast round: Post ipo equity
What company datasets say MoonLake Immunotherapeutics raised
Funding, as reported
Reported in all515Min the source's currency
Rounds3
Last roundPost ipo equity
Last round dateJun 2023
Investors listed10
Founders and team
From MoonLake Immunotherapeutics's own website: 2 founders, 18 on the team.
Jorge Santos da SilvaChairman & Chief Executive Officer, Founder
Kristian ReichFounder & Chief Scientific Officer
- Eva CullenVice-President Medical Affairs & Research
- Joana CortezAssociate Vice-President Legal & Compliance
- João NevesAssociate Vice-President IT
- Kate Wright Ph.D.Associate Vice-President Quality & PMO
- Luciana MarquesAssociate Vice-President of HR, People and Culture
- Matthias BodenstedtChief Financial Officer
- Nuala BrennanChief Clinical Development Officer
- Oliver DaltropChief Technical Officer
- Roman Akbar-HaaseChief of Staff to the Executive Board
- Wulf BoecherChief Medical Officer
- Alex GodwoodExecutive Director Biometrics
- Andrew J. PhillipsChairperson of The Compensation Committee
- Catherine MoukheibirChairperson of The Audit Committee
- Mark AntiolaSenior Director Finance
- Martin YatemanSenior Director Bioanalysis Clinical Development
- Nicolas MosimannGeneral Counsel
- Ramnik XavierDirector
- Spike LoyLead Independent Director
Biotechnology in Switzerland
Startups like it
Is this your company?
Add your raise, your deck and your story, and put MoonLake Immunotherapeutics in front of investors. Or tell us what we have wrong.